Chul Kim

Chul Kim

Georgetown University - Washington / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1411673
person_outline Chul Kim's MOST POPULAR ARTICLES
1-) Cancer drugs approved on the basis of a surrogate end point and subsequent overall survival: an analysis of 5 years of US Food and Drug Administration approvalsC Kim, V PrasadJAMA Internal Medicine 175 (12), 1992-1994, 20153362015
2-) The strength of association between surrogate end points and survival in oncology: a systematic review of trial-level meta-analysesV Prasad, C Kim, M Burotto, A VandrossJAMA internal medicine 175 (8), 1389-1398, 20152952015
3-) Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 studyG Giaccone, C Kim, J Thompson, C McGuire, B Kallakury, JJ Chahine, ...The Lancet Oncology 19 (3), 347-355, 20182542018
4-) Safety and efficacy of immune checkpoint inhibitor therapy in patients with HIV infection and advanced-stage cancer: a systematic reviewMR Cook, C KimJAMA oncology 5 (7), 1049-1054, 20192192019
5-) Adiponectin levels and the risk of hypertension: a systematic review and meta-analysisDH Kim, C Kim, EL Ding, MK Townsend, LA LipsitzHypertension 62 (1), 27-32, 20132032013